Jamala M. Arland's most recent trade in Genworth Financial Inc - Ordinary Shares - Class A was a trade of 90,014 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 26, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Genworth Financial Inc - O... | Jamala M. Arland | Pres. & CEO, U.S. Life Ins. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 90,014 | 90,014 | - | - | Restricted Stock Units | |
Genworth Financial Inc - O... | Jamala M. Arland | Pres. & CEO, U.S. Life Ins. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 27,144 | 49,078 (0%) | 0% | - | Common Stock | |
Genworth Financial Inc - O... | Jamala M. Arland | Pres. & CEO, U.S. Life Ins. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 27,144 | 54,289 | - | - | Restricted Stock Units | |
Genworth Financial Inc - O... | Jamala M. Arland | Pres. & CEO, U.S. Life Ins. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.65 per share. | 26 Feb 2025 | 8,171 | 40,907 (0%) | 0% | 6.6 | 54,337 | Common Stock |
Genworth Financial Inc - O... | Jamala M. Arland | Pres. & CEO, U.S. Life Ins. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 10,946 | 25,809 (0%) | 0% | - | Common Stock | |
Genworth Financial Inc - O... | Jamala M. Arland | Pres. & CEO, U.S. Life Ins. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 10,946 | 10,946 | - | - | Restricted Stock Units | |
Genworth Financial Inc - O... | Jamala M. Arland | Pres. & CEO, U.S. Life Ins. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.30 per share. | 14 Feb 2025 | 3,875 | 21,934 (0%) | 0% | 7.3 | 28,288 | Common Stock |
Genworth Financial Inc - O... | M. Jamala Arland | EVP-U.S. Life Insurance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 81,433 | 81,433 | - | - | Restricted Stock Units | |
Genworth Financial Inc - O... | Jamala M. Arland | EVP-U.S. Life Insurance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 10,945 | 18,738 (0%) | 0% | - | Class A Common Stock | |
Genworth Financial Inc - O... | M. Arland Jamala | EVP-U.S. Life Insurance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 10,945 | 21,892 | - | - | Restricted Stock Units | |
Genworth Financial Inc - O... | Jamala M. Arland | EVP-U.S. Life Insurance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.19 per share. | 16 Feb 2024 | 3,875 | 14,863 (0%) | 0% | 6.2 | 23,986 | Class A Common Stock |